Therefore, the association between melanoma and non-melanoma skin cancers in patients with BRCA mutations remains an active area of investigation, and there are no official recommendations on to perform skin screening in BRCA1/2 mutation carriers. This evidence concerns the gene BRCA1 and skin neoplasm.